Penny Stock News: Why This Stock’s 28% Run Will Continue

Shares of drug companies developing Ebola treatments have at turns soared and tanked over the past couple months amid speculation and hype....

This Big-Cap "Ebola Stock" Is Also a Dividend Aristocrat

Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the...

Pages 1 of 1